<code id='B82B80C7E9'></code><style id='B82B80C7E9'></style>
    • <acronym id='B82B80C7E9'></acronym>
      <center id='B82B80C7E9'><center id='B82B80C7E9'><tfoot id='B82B80C7E9'></tfoot></center><abbr id='B82B80C7E9'><dir id='B82B80C7E9'><tfoot id='B82B80C7E9'></tfoot><noframes id='B82B80C7E9'>

    • <optgroup id='B82B80C7E9'><strike id='B82B80C7E9'><sup id='B82B80C7E9'></sup></strike><code id='B82B80C7E9'></code></optgroup>
        1. <b id='B82B80C7E9'><label id='B82B80C7E9'><select id='B82B80C7E9'><dt id='B82B80C7E9'><span id='B82B80C7E9'></span></dt></select></label></b><u id='B82B80C7E9'></u>
          <i id='B82B80C7E9'><strike id='B82B80C7E9'><tt id='B82B80C7E9'><pre id='B82B80C7E9'></pre></tt></strike></i>

          Home / fashion / hotspot

          hotspot


          hotspot

          author:fashion    Page View:76
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In